Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Treat-to-Target Strategy Evaluated for Fibromyalgia Care

  |  Issue: September 2017  |  

Susan Bernstein is a freelance medical journalist based in Atlanta.

References

  1. Ramiro S, Landewe RBM, van der Heijde D, et al. Is treat-to-target really working? A longitudinal analysis in biodam (Abstract 3184). Arthritis Rheumatol. 2015;(67)suppl 10.
  2. Häuser W, Clauw DJ, Fitzcharles MA. Treat-to-target strategy for fibromyalgia: Opening the dialogue. Arthritis Care Res (Hoboken). 2017 Apr;69(4):462–466.
  3. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600–610.
  4. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011 Jun;38(6):1113–1122.
  5. Quieroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013 Aug;17(8):356.
  6. Clauw DJ. Fibromyalgia: A clinical review. JAMA. 2014 Apr 16;311(15):1547–1555.
  7. Hauser W, Ablin J, Fitzcharles MA, et al. Fibromyalgia. Nat Rev Dis Primers. 2015 Aug 13;1:15022.
  8. Bennett RM, Friend R, Marcus D, et al. Criteria for the diagnosis of fibromyalgia: Validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1364–1373.
  9. Choy E, Perrot S, Leon T, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010 Apr 26;10:102.
  10. Vincent A, Hoskin TL, Whipple MO, et al. OMERACT-based fibromyalgia symptom subgroups: An exploratory cluster analysis. Arthritis Res Ther. 2014 Oct 16;16(5):463.
  11. Kashikar-Zuck S, Cunningham N, Sil S, et al. Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood. Pediatrics. 2014 Mar;133(3):e592–e600.
  12. Ablin J, Fitzcharles MA, Buskila D, et al. Treatment of fibromyalgia syndrome: Recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Alternat Med. 2013;2013:485272.
  13. Luciano JV, Guallar JA, Aguado J, et al. Effectiveness of group acceptance and commitment therapy for fibromyalgia: A 6-month randomized controlled trial (EFFIGACT study). Pain. 2014 Apr;155(4):693–702.
  14. Hauser W, Klose P, Langhorst J, et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther. 2010;12(3):R79.
  15. Bernardy K, Klose P, Busch AJ, et al. Cognitive-behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013 Sep 10;(9)CD009796.
  16. Bennett RM, Friend R, Jones KD, et al. The revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120.
  17. Hauser W, Brahler E, Wolfe F, et al. Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: Surveys with patients of three different settings. J Psychosom Res. 2014 Apr;76(4):307–311.

Related Articles

    Revising Fibromyalgia: One Year Later

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Cannabis for Pain Relief: An Area Ripe for Research

    Medical cannabis may benefit patients experiencing pain, and rheumatologists should be able to discuss its potential risks and benefits with their patients. Here are insights from Dr. Mary Ann Fitzcharles on current research, patient use and more.

    Is Fibromyalgia Overdiagnosed?

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

    Africa Studio/shutterstock.com

    Evidence Needed to Support Marijuana Use for Pain Relief in Rheumatologic Conditions

    With the chronic pain and other health issues that many rheumatology patients face every day, it’s natural for rheumatologists and their patients to wonder if cannabinoid treatments are of any help. At this point, there is insufficient evidence to recommend cannabinoid treatments to manage rheumatic diseases, according to a review article published in the May…